-
公开(公告)号：EP1569943A1
公开(公告)日：2005-09-07
申请号：EP03812388.1
申请日：2003-12-05
IPC分类号： C07F3/00
CPC分类号： C07C229/76
摘要： The present invention provides methods for preparation of metallic amino acid chelates that are electrically neutral and free of interfering ions, by reacting a metal carbonate and an acidic amino acid in an aqueous solution, and the uses of said metallic amino acid chelates. The metallic amino acid chelates can be added to a product such as medical supplies, foods, beverages, cosmetics, feeds, etc., with maintaining the stability of the product at a variety of temperature and pH ranges and also having no effect on the properties of the product, including taste and appearance.
-
12.发明公开
公开(公告)号：EP1954295A4
公开(公告)日：2013-08-07
申请号：EP06843850
申请日：2006-11-18
申请人： MD BIOALPHA CO LTD
发明人： PARK MYUNG-GYU , KUON MIN-KYUNG
IPC分类号： A61K31/7072 , A61P27/02
CPC分类号： A61K31/7072
-
13.发明公开Pharmaceutical composition for obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases 有权用于肥胖症，糖尿病，代谢综合征，神经变性疾病和线粒体功能障碍的药物组合物
公开(公告)号：EP2532390A3
公开(公告)日：2013-02-20
申请号：EP12175609.2
申请日：2006-02-15
发明人： Yoo, Sang-Ku , Park, Myunggyu , Jo, In Geum , Kwak, Tae-hwan
IPC分类号： A61P3/04 , A61P3/10 , A61P3/00 , A61P1/16 , A61P9/10 , A61P29/00 , A61P27/02 , A61P9/12 , A61K31/352 , A61K31/353 , A61K31/343
CPC分类号： A61K31/352 , A61K8/498 , A61K9/0014 , A61K9/06 , A61K9/146 , A61K9/2054 , A61K31/343 , A61K31/353 , A61K31/453 , A61Q19/00
摘要： Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
-
14.发明公开Pharmaceutical composition for obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases 有权Pharmazutische ZusammensetzungfürLeberkrankheiten。
公开(公告)号：EP2532390A2
公开(公告)日：2012-12-12
申请号：EP12175609.2
申请日：2006-02-15
发明人： Yoo, Sang-Ku , Park, Myunggyu , Jo, In Geum , Kwak, Tae-hwan
IPC分类号： A61P3/04 , A61P3/10 , A61P3/00 , A61P1/16 , A61P9/10 , A61P29/00 , A61P27/02 , A61P9/12 , A61K31/352 , A61K31/353 , A61K31/343
CPC分类号： A61K31/352 , A61K8/498 , A61K9/0014 , A61K9/06 , A61K9/146 , A61K9/2054 , A61K31/343 , A61K31/353 , A61K31/453 , A61Q19/00
摘要： Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
摘要翻译： 提供了用于治疗和预防肥胖症，糖尿病，代谢综合征，退行性疾病和线粒体功能障碍相关疾病的药物组合物，其包含：治疗有效量的下式I表示的化合物或其药学上可接受的盐前药， 溶剂合物或其异构体，以及药学上可接受的载体，稀释剂或赋形剂，或其任何组合。
-
15.发明公开Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases 审中-公开用于治疗或预防疾病，包括肥胖症，糖尿病，代谢综合征，神经变性疾病和线粒体功能障碍的药物组合物
公开(公告)号：EP2532388A2
公开(公告)日：2012-12-12
申请号：EP12175605.0
申请日：2006-02-15
发明人： Yoo, Sang-Ku , Park, Myunggyu , Jo, In Geum , Kwak, Tae-hwan
IPC分类号： A61P3/04 , A61P3/10 , A61P3/00 , A61P1/16 , A61P9/10 , A61P29/00 , A61P27/02 , A61P9/12 , A61K31/352 , A61K31/353 , A61K31/343
CPC分类号： A61K31/352 , A61K8/498 , A61K9/0014 , A61K9/06 , A61K9/146 , A61K9/2054 , A61K31/343 , A61K31/353 , A61K31/453 , A61Q19/00
摘要： Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
摘要翻译： 提供了一种用于肥胖症，糖尿病，代谢综合征，退行性疾病和线粒体功能障碍有关的疾病的治疗和预防的药物组合物，包括：由下式I或其药学上可接受的盐，前药代表一治疗有效量的化合物， 溶剂化物或异构体，以及药学上可接受的载体，稀释剂或赋形剂的，或它们的任何组合。
-
16.发明公开PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DISEASES INVOLVING OBESITY, DIABETES, METABOLIC SYNDROME, NEURO-DEGENERATIVE DISEASES AND MITOCHONDRIA DYSFUNCTION DISEASES 有权药物组合物治疗或疾病的预防与肥胖，糖尿病，代谢综合征，神经退行性疾病，线粒体疾病MALFUNCTION连词
公开(公告)号：EP1848432A4
公开(公告)日：2009-12-30
申请号：EP06715982
申请日：2006-02-15
申请人： MD BIOALPHA CO LTD , KT & G CO LTD
发明人： YOO SANG-KU , PARK MYUNGGYU , JO IN GEUN , KWAK TAEHWAN
IPC分类号： A61P3/04 , A61K31/352 , A61K31/353 , A61P1/16 , A61P3/00 , A61P3/10 , A61P9/10 , A61P9/12 , A61P27/02 , A61P29/00
CPC分类号： A61K31/352 , A61K31/343 , A61K31/353 , A61K31/453
摘要： Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
-
17.发明公开
公开(公告)号：EP1994168A1
公开(公告)日：2008-11-26
申请号：EP07708979.5
申请日：2007-02-15
发明人： PARK, Myung-Gyu , YOO, Sang-Ku , JO, In Geun , KWAK, Taehwan
IPC分类号： C12Q1/26
CPC分类号： C12Q1/26 , A61K31/12 , A61K31/343 , A61K38/44 , C12Y106/05002
摘要： Provided is a method capable of effectively treating various diseases associated with energy excess, such as obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, via elevation of an NAD(P)+ZNAD(P)H ratio by increasing an NAD(P)+ concentration in vivo or in vitro through use of NAD(P)H as a substrate or coenzyme by oxidoreductase such as NAD(P)H:quinone oxidoreductase (NQO1), a method of screening a drug for the same and a therapeutic drug.
-
18.发明授权Use of a fraction having anti-cancer activity, isolated from leaves and stems of ginseng (Panax) 有权一小部分具有癌症的抑制活性，从叶中分离和使用茎人参（人参）
公开(公告)号：EP1507544B1
公开(公告)日：2015-05-06
申请号：EP03725845.6
申请日：2003-05-28
发明人： KWAK, Tae Hwan 103-503, Seogeunaemaeul SK Apt. , SHIN, Myoung Sook 611, Samjeongateutel , KIM, Ji Yeon , PARK, Jong-Kook
IPC分类号： A61P35/00 , A61K36/258
CPC分类号： A61K36/258 , A23L33/105 , A61K31/191 , A61K31/225 , A61K31/7004 , A61K31/7012 , A61K31/702 , A61K2300/00
-
19.发明授权
公开(公告)号：EP1954295B1
公开(公告)日：2014-08-06
申请号：EP06843850.6
申请日：2006-11-18
发明人： PARK, Myung-Gyu , KUON, Min-Kyung
IPC分类号： A61K31/7072 , A61P27/02
CPC分类号： A61K31/7072
-
公开(公告)号：EP2532388A3
公开(公告)日：2013-03-06
申请号：EP12175605.0
申请日：2006-02-15
发明人： Yoo, Sang-Ku , Park, Myunggyu , Jo, In Geum , Kwak, Tae-hwan
IPC分类号： A61P3/04 , A61P3/10 , A61P3/00 , A61P1/16 , A61P9/10 , A61P29/00 , A61P27/02 , A61P9/12 , A61K31/352 , A61K31/353 , A61K31/343
CPC分类号： A61K31/352 , A61K8/498 , A61K9/0014 , A61K9/06 , A61K9/146 , A61K9/2054 , A61K31/343 , A61K31/353 , A61K31/453 , A61Q19/00
摘要： Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
-
-
-
-
-
-
-
-
-
搜索结果
24 条记录 (耗时 0.016 秒)
